Jennifer E. Cook
Ms. Jennifer E. Cook is an Independent Director at Denali Therapeutics, Inc. She is on the Board of Directors at Gyroscope Therapeutics Ltd., Jazz Pharmaceuticals Plc, Gyroscope Therapeutics Holdings Plc, BridgeBio Pharma, Inc., Denali Therapeutics, Inc., Ambys Medicines, Inc. and BridgeBio Pharma LLC. Ms. Cook was previously employed as a Chief Executive Officer & Director by GRAIL, Inc. (California), a Senior VP & Global Head-Clinical Operations by Roche Pharmaceuticals, Inc., a Senior Vice President-Immunology & Ophthalmology by Genentech, Inc., and a Principal by Prizm Pharmaceuticals, Inc. She received her undergraduate degree from Stanford University, a graduate degree from Stanford University and an MBA from Haas School of Business.
|06/02/2021||2,074||Award at $0 per share.||0|
|06/01/2021||3,253||Derivative/Non-derivative trans. at $0 per share.||0|